Skip Capital

Activity from announced rounds

All recorded activity
Rounds participated in
4
Confirmed lead rounds
0
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$100M
3 disclosed · full round size, not this investor’s share

By stage

Series B2
Seed1
Undisclosed1

By primary sector

Healthtech2
Robotics2

By country

United States3
Australia1

Rounds

4 in all activity
Remedy Robotics

Remedy Robotics develops AI-enabled robotic systems for endovascular procedures, aiming to extend specialist cardiovascular care to more hospitals.

$62MSeries B
Participant
Alloy Robotics

AI agents analyze robot data to diagnose fleet failures

$8MSeed
Role not disclosed
August Robotics

Autonomous robot fleets for construction, industrial layout and exhibition floor marking.

$30MSeries B
Participant
Timeshifter

Develops circadian technology products for jet lag and shift work

UndisclosedUndisclosed
Role not disclosed